WallStreetZenWallStreetZen

NASDAQ: SNDX
Syndax Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Syndax Pharmaceuticals earnings were -$220.8M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest SNDX earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$49.4M, up 15.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SNDX reported annual earnings of -$285.4M, with -10.5% growth.

SNDX earnings history

Current Revenue
$252.3M
Current Earnings
-$220.8M
Current Profit Margin
-87.5%

SNDX Return on Equity

Current Company
-372.9%
Current Industry
-5.1%
Current Market
33.5%
SNDX's Return on Equity (-372.9%)... subscribe to Premium to read more.
High Return on Equity Performance

SNDX Return on Assets

Current Company
-39.1%
Current Industry
-3.9%
SNDX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SNDX announces earnings.

SNDX Return on Capital Employed

Current Company
-29.53%
Current Industry
-1.3%
SNDX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SNDX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SNDX-$177.54M-$220.77MN/A-$2.51
GHRS-$55.69M-$56.41MN/A-$0.92
ABCL-$146.92M-$143.96MN/A-$0.48
SEPN-$31.91M-$36.04MN/A-$0.81
FTRE$94.30M-$85.20MN/A-$0.84
View Top Biotech Stocks

Syndax Pharmaceuticals Earnings Reports & History FAQ

What were Syndax Pharmaceuticals's earnings last quarter?

On SNDX's earnings call on Aug 4, 2026, Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q2 2026 earnings per share (EPS) of -$0.55, up 33.73% year over year. Total SNDX earnings for the quarter were -$49.36 million. In the same quarter last year, Syndax Pharmaceuticals's earnings per share (EPS) was -$0.83.

If you're new to stock investing, here's how to buy Syndax Pharmaceuticals stock.

Is Syndax Pharmaceuticals profitable or losing money?

As of the last Syndax Pharmaceuticals earnings report, Syndax Pharmaceuticals is currently losing money. Syndax Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$220.77 million, a 34.1% decrease year over year.

What was SNDX's earnings growth in the past year?

As of Syndax Pharmaceuticals's earnings date in Aug 4, 2026, Syndax Pharmaceuticals's earnings has grown year over year. SNDX earnings in the past year totalled -$220.77 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.